[
    [
        {
            "time": "",
            "original_text": "快讯|智飞生物：前两大股东陆续减持套现 自产疫苗业务频频受阻 减持股份",
            "features": {
                "keywords": [
                    "智飞生物",
                    "减持",
                    "自产疫苗",
                    "业务受阻"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "快讯|智飞生物：前两大股东陆续减持套现 自产疫苗业务频频受阻 减持股份",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "快讯|智飞生物：股东吴冠江通过大宗交易方式转让公司股份1.92% 减持股份",
            "features": {
                "keywords": [
                    "智飞生物",
                    "吴冠江",
                    "大宗交易",
                    "减持股份"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "快讯|智飞生物：股东吴冠江通过大宗交易方式转让公司股份1.92% 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "【山证医药】2月疫苗批签发数据跟踪：疫情影響有限，行业批签发有序进行",
            "features": {
                "keywords": [
                    "山证医药",
                    "疫苗",
                    "批签发",
                    "疫情",
                    "行业数据"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【山证医药】2月疫苗批签发数据跟踪：疫情影響有限，行业批签发有序进行",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]